EUVIMEDEUVIMED entdecken
Open Access

DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease

Julie Xia Zhou, Linda Xiaoyan Li, Hongbing Zhang, Ewud Agborbesong, Peter C Harris, James P Calvet, Xiaogang Li

Kidney International · 2024

DOI: 10.1016/j.kint.2024.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von Julie Xia Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Mi…. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, DNA (Cytosine-5-)-Methyltransferase 1, Epigenesis, Genetic, DNA Methylation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Yale University, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alteration of DNA methylation leads to diverse diseases, and the dynamic changes of DNA methylation (DNAm) on sets of CpG dinucleotides in mammalian genomes are termed "DNAm age" and "epigenetic clocks" that can predict chronological age. However, whether and how dysregulation of DNA methylation promotes cyst progression and epigenetic age acceleration in autosomal dominant polycystic kidney disease (ADPKD) remains elusive. Here, we show that DNA methyltransferase 1 (DNMT1) is upregulated in cystic kidney epithelial cells and tissues and that knockout of Dnmt1 and targeting DNMT1 with hydralazine, a safe demethylating agent, delays cyst growth in Pkd1 mutant kidneys and extends life span of Pkd1 conditional knockout mice. With methyl-CpG binding domain (MBD) protein-enriched genome sequencing (MBD-seq), DNMT1 chromatin immunoprecipitation (ChIP)-sequencing and RNA-sequencing analysis, we identified two novel DNMT1 targets, PTPRM and PTPN22 (members of the protein tyrosine phosphatase family). PTPRM and PTPN22 function as mediators of DNMT1 and the phosphorylation and activation of PKD-associated signaling pathways, including ERK, mTOR and STAT3. With whole-genome bisulfide sequencing in kidneys of patients with ADPKD versus normal individuals, we found that the methylation of epigenetic clock-associated genes was dysregulated, supporting that epigenetic age is accelerated in the kidneys of patients with ADPKD. Furthermore, five epigenetic clock-associated genes, including Hsd17b14, Itpkb, Mbnl1, Rassf5 and Plk2, were identified. Thus, the diverse biological roles of these five genes suggest that their methylation status may not only predict epigenetic age acceleration but also contribute to disease progression in ADPKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantDNA (Cytosine-5-)-Methyltransferase 1Epigenesis, GeneticDNA MethylationTRPP Cation ChannelsMice, KnockoutAnimalsHumansMiceSignal TransductionDisease Models, AnimalMaleDisease ProgressionKidney

Stichwörter der Autor:innen

ADPKDDNA methylationcell signalingepigenetic age accelerationtranscription regulation

Substanzen

DNA (Cytosine-5-)-Methyltransferase 1TRPP Cation ChannelsDnmt1 protein, mouseDNMT1 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: zhou.xia@mayo.edu.
  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: li.xiaogang@mayo.edu.

Förderung

  • NIDDK NIH HHS
  • Yale University
  • U.S. Department of Defense
  • NIH
  • PKD Foundation

Zitieren

APA

Zhou, J. X., Li, L. X., Zhang, H., Agborbesong, E., Harris, P. C., Calvet, J. P., & Li, X. (2024). DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. Kidney International. https://doi.org/10.1016/j.kint.2024.04.017

Vancouver

Zhou JX, Li LX, Zhang H, Agborbesong E, Harris PC, Calvet JP, et al. DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. Kidney International. 2024. doi:10.1016/j.kint.2024.04.017

BibTeX
@article{Zhou2024,
  author = {Zhou, Julie Xia and Li, Linda Xiaoyan and Zhang, Hongbing and Agborbesong, Ewud and Harris, Peter C and Calvet, James P and Li, Xiaogang},
  title = {DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease},
  journal = {Kidney International},
  year = {2024},
  doi = {10.1016/j.kint.2024.04.017}
}
Kostenlos starten →